Annual report 2022

— medmix at a glance

medmix Surgery: ErgoSyringe

medmix at a glance

medmix at a glance

We design, develop, manufacture and deliver innovative high-precision devices and services for the mixing, application and delivery of liquids in a wide range of viscosities with up to two components for the healthcare, consumer and industrial end markets.

Our group is organized into two business areas — Healthcare and Consumer & Industrial — and five market segments:

All of our segments benefit from our diversified exposure to growing end markets that are supported by long-term mega trends, such as the growing middle class, an aging population and the trend towards increased urbanization, homecare and sustainability.

Helping people live healthier and more confident lives

Our Healthcare business area is divided into the Dental, Drug Delivery and Surgery segments. In the Dental segment, our customers use our mixing and delivery devices for a broad range of applications, such as prosthetics, restorations, anesthetics and aesthetics. The Drug Delivery segment offers drug delivery devices that are used to inject fertility drugs and growth hormones and to treat niche diabetes indications, osteoporosis and rare diseases. In the Surgery segment, our mixing and delivery devices are used to inject bone tissue and to apply hemostatic sealants for internal and external wound treatment during surgical procedures.

Innovative, high-precision delivery

In our Consumer & Industrial business area, we operate through the Industry and Beauty segments. In the Industry segment, our dispensers, cartridges, and mixers are used in the construction, transportation (automotive, railways and aerospace), electronics assembly, infrastructure and DIY industries. In the Beauty segment, our micro-brushes are used for the application of makeup treatments, such as lash & brow serum or spot correctors, as well as for the application of skincare treatments such as anti-aging serums, e.g., vitamin C serums. 

We have a strong legacy of setting industry standards through the continuous launch of innovative products in the business-to-business (B2B) markets in which we operate.

Our intellectual property

In 2022, close to half our revenue was derived from products protected by approximately 900 active patents and other medmix intellectual property (IP) rights such as trademarks and registered designs. In addition, we benefit from well-established, co-development and customer-centric innovation processes that have always had a high priority at medmix, resulting in a thorough understanding of our customers’ needs captured through extensive design and production know-how.

We operate 14 production, logistics and distribution sites throughout the world, most of which are centered around our plastic injection molding core competencies and serve more than one market segment to satisfy the needs of our local customers in a timely and flexible manner.